uniQure (QURE) Stock Forecast & Price Target

Q: What analysts cover uniQure?

uniQure has been rated by research analysts at Barclays , HC Wainwright , Royal Bank Of Canada , The Goldman Sachs Group , UBS Group , Weiss Ratings , Wells Fargo & Company , William Blair , and Wolfe Research in the past 90 days.

$21.78 -0.74 (-3.29%)

Closing price 10/16/2026 04:00 PM Eastern

Extended Trading

$21.65 -0.13 (-0.60%)

As of 10/16/2026 07:52 PM Eastern

Compare

uniQure - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 17 Analyst Ratings

Sell
1

Hold
3

Buy
13

Based on 17 Wall Street analysts who have issued ratings for uniQure in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 17 analysts, 1 has given a sell rating, 3 have given a hold rating, 12 have given a buy rating, and 1 has given a strong buy rating for QURE.

Consensus Price Target

$53.25
144.49% Upside

According to the 17 analysts' twelve-month price targets for uniQure, the average price target is $53.25. The highest price target for QURE is $80.00, while the lowest price target for QURE is $28.00. The average price target represents a forecasted upside of 144.49% from the current price of $21.78.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for QURE and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for uniQure and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

QURE Analyst Ratings Over Time

Type	Current Forecast 10/18/25 to 10/18/26	1 Month Ago 9/18/25 to 9/18/26	3 Months Ago 7/20/25 to 7/20/26	1 Year Ago 10/18/24 to 10/18/25
Strong Buy	1 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	12 Buy rating(s)	14 Buy rating(s)	12 Buy rating(s)	9 Buy rating(s)
Hold	3 Hold rating(s)	2 Hold rating(s)	4 Hold rating(s)	1 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$53.25	$65.00	$64.17	$71.75
Forecasted Upside	144.49% Upside	47.73% Upside	61.63% Upside	23.71% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

QURE Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

QURE Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

uniQure Stock vs. The Competition

Type	uniQure	Healthcare Companies	Broader Market
Consensus Rating Score	2.76	2.32	2.53
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	144.49% Upside	1,213.76% Upside	18.02% Upside
News Sentiment Rating	Neutral News See Recent QURE News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Show

Rating

Upside/Downside

Action

Report Date

0 Results

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
10/15/2026	UBS Group 4 of 5 stars	Joon Lee Not Rated	Reiterated Rating	Buy	$27.00 ➝ $48.00	+128.90%
10/5/2026	Barclays 3 of 5 stars	Eliana Merle Not Rated	Downgrade	Overweight ➝ Equal Weight	$60.00 ➝ $28.00	+19.35%
10/2/2026	Royal Bank Of Canada 2 of 5 stars	Luca Issi 5 of 5 stars	Lower Target	Outperform	$65.00 ➝ $48.00	+105.39%
9/30/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Salveen Richter Subscribe to MarketBeat All Access to unlock analyst rankings	Lower Target	Neutral	$46.00 ➝ $31.00	+26.48%
9/29/2026	Wells Fargo & Company Subscribe to MarketBeat All Access to unlock brokerage rankings	Yanan Zhu Subscribe to MarketBeat All Access to unlock analyst rankings	Reiterated Rating	Overweight	$75.00	+206.00%
9/29/2026	HC Wainwright Subscribe to MarketBeat All Access to unlock brokerage rankings	Patrick R. Trucchio Subscribe to MarketBeat All Access to unlock analyst rankings	Reiterated Rating	Buy
9/23/2026	William Blair Subscribe to MarketBeat All Access to unlock brokerage rankings	Sami Corwin Subscribe to MarketBeat All Access to unlock analyst rankings	Upgrade	Strong-Buy
9/21/2026	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings		Upgrade	Sell (E+) ➝ Sell (D-)
7/29/2026	Wolfe Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Rudy Li Subscribe to MarketBeat All Access to unlock analyst rankings	Upgrade	Peer Perform ➝ Outperform	$65.00	+62.22%
6/25/2026	Mizuho Subscribe to MarketBeat All Access to unlock brokerage rankings	Uy Ear Subscribe to MarketBeat All Access to unlock analyst rankings	Boost Target	Outperform	$35.00 ➝ $68.00	+39.20%
Why Some AI Stocks Already Surged Over 300 Percent (Ad) Jason Bodner's system flagged Nvidia before a 7000 percent run, Super Micro Computer before a 2600 percent run, and Vertiv before a 1900 percent run. Now he's tracking a radical light-speed technology that could make AI 100 times faster and 100 times more energy efficient. Stocks tied to it have already climbed 133 percent, 217 percent, and 320 percent. See the light-speed AI technology and get Jason's number one pick free
6/18/2026	Leerink Partners Subscribe to MarketBeat All Access to unlock brokerage rankings	Joseph Schwartz Subscribe to MarketBeat All Access to unlock analyst rankings	Boost Target	Outperform	$36.00 ➝ $70.00	+45.35%
6/17/2026	Cantor Fitzgerald Subscribe to MarketBeat All Access to unlock brokerage rankings		Upgrade	Neutral ➝ Overweight	$61.00	+28.79%
5/5/2026	Stifel Nicolaus Subscribe to MarketBeat All Access to unlock brokerage rankings	Paul Matteis Subscribe to MarketBeat All Access to unlock analyst rankings	Set Target		$28.00	+35.56%
4/30/2026	Chardan Capital Subscribe to MarketBeat All Access to unlock brokerage rankings	Daniil Gataulin Subscribe to MarketBeat All Access to unlock analyst rankings	Boost Target	Buy	$31.00 ➝ $37.00	+85.46%
3/3/2026	Sanford C. Bernstein Subscribe to MarketBeat All Access to unlock brokerage rankings		Downgrade	Market Perform
3/3/2026	TD Cowen Subscribe to MarketBeat All Access to unlock brokerage rankings		Reiterated Rating	Buy
11/4/2025	Benchmark Subscribe to MarketBeat All Access to unlock brokerage rankings		Reiterated Rating	Buy
9/25/2025	Guggenheim Subscribe to MarketBeat All Access to unlock brokerage rankings	Debjit Chattopadhyay Subscribe to MarketBeat All Access to unlock analyst rankings	Boost Target	Buy	$28.00 ➝ $95.00	+100.00%
12/10/2024	Raymond James Financial Subscribe to MarketBeat All Access to unlock brokerage rankings	Danielle Brill Subscribe to MarketBeat All Access to unlock analyst rankings	Upgrade	Outperform ➝ Strong-Buy	$20.00 ➝ $52.00	+612.82%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 03:56 PM ET.

QURE Forecast - Frequently Asked Questions

According to the research reports of 17 Wall Street equities research analysts, the average twelve-month stock price forecast for uniQure is $53.25, with a high forecast of $80.00 and a low forecast of $28.00.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for uniQure in the last year. There is currently 1 sell rating, 3 hold ratings, 12 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" QURE shares.

According to analysts, uniQure's stock has a predicted upside of 144.49% based on their 12-month stock forecasts.

Over the previous 90 days, uniQure's stock had 3 upgrades and 1 downgrade by analysts.

uniQure has been rated by research analysts at Barclays, HC Wainwright, Royal Bank Of Canada, The Goldman Sachs Group, UBS Group, Weiss Ratings, Wells Fargo & Company, William Blair, and Wolfe Research in the past 90 days.

Analysts like uniQure more than other "healthcare" companies. The consensus rating for uniQure is Moderate Buy while the average consensus rating for "healthcare" companies is Hold. Learn more on how QURE compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With uniQure Recommendations

MarketBeat monitors more than a dozen sources for uniQure analyst ratings, with the most recent rating issued on 10/15/2026.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

uniQure (QURE) Stock Forecast & Price Target